By DENISE GRADY An exhaustive new report meant to address public fears about possible links between breast cancer and the environment findsevidence strong enough to make only a few firm recommendations, most already well known and none with a large proven benefit. The most consistent data suggest that women can reduce their risk by avoiding…
By ANDREW POLLACK The commissioner of the Food and Drug Administration on Friday revoked the approval of the drug Avastin as a treatment for breast cancer, ruling in an emotional issue that pitted the hopes of some desperate patients against the statistics of clinical trials. The commissioner, Dr. Margaret A. Hamburg, said that the drug…
By ANDREW POLLACK The commissioner of the Food and Drug Administration on Friday revoked the approval of the drug Avastin as a treatment for breast cancer, ruling in an emotional issue that pitted the hopes of some desperate patients against the statistics of clinical trials. The commissioner, Dr. Margaret A. Hamburg, said that the drug…
Friends of Cancer Research, with the Support of over 25 Leading Advocacy Organizations, Releases Report Identifying Comparative Effectiveness Research (CER) Priority Studies in Cancer Today Friends of Cancer Research is releasing a new report: Expanding Comparative Effectiveness Research: Priority Areas in Oncology.The report being released today is the outgrowth of the June 2011 Friends of Cancer…
Friends of Cancer Research, with the Support of over 25 Leading Advocacy Organizations, Releases Report Identifying Comparative Effectiveness Research (CER) Priority Studies in Cancer Today Friends of Cancer Research is releasing a new report: Expanding Comparative Effectiveness Research: Priority Areas in Oncology.The report being released today is the outgrowth of the June 2011 Friends of Cancer Research…
By ANNA YUHANANOV and ALINA SELYUKH Releasing a report on the approvals in the year ended on September 30 , the Food and Drug Administration also said it had approved 35 drugs, the second-highest number in the past decadeafter 37 new treatments reached the U.S. market in 2009. The FDA also used the report to…
By ANNA YUHANANOV and ALINA SELYUKH Releasing a report on the approvals in the year ended on September 30 , the Food and Drug Administration also said it had approved 35 drugs, the second-highest number in the past decadeafter 37 new treatments reached the U.S. market in 2009. The FDA also used the report to…
By GARDINER HARRIS President Obama will issue an executive order on Monday that the administration hopes will help resolvea growing number of critical shortages of vital medicines used to treat life-threatening illnesses, among them several forms of cancer and bacterial infections. The order offers drug manufacturers and wholesalers both a helping hand and a gloved…
By GARDINER HARRIS President Obama will issue an executive order on Monday that the administration hopes will help resolvea growing number of critical shortages of vital medicines used to treat life-threatening illnesses, among them several forms of cancer and bacterial infections. The order offers drug manufacturers and wholesalers both a helping hand and a gloved…
By ANNA YUKHANANOV A bill that would loosen conflict of interest rules for advisers to the Food and Drug Administration has been proposed by three U.S. senators seeking to speed up review times for medical devices. The measure would reverse 2007 legislation that barred experts who had financial ties to a company or its competitor from…
